We have been funding expert research since 2016, aiming to ensure that every child and young person has a safe and effective treatment for their cancer, and that they can live long and happy lives post-treatment.
It is particularly difficult to treat some groups of childhood cancer patients, especially infants in their first weeks of life. This application is to fund this rapidly developing research programme for two years, involving the treatment of 150-200.
Testing a new type of targeted treatment that applies to multiple types of childhood cancers.
Looking at how cancer cells alter the scaffolding inside the body that organises cells in order to spread and make new tumours.
Creating an immunotherapy that can be delivered to patients more quickly and cost-effectively.
Testing medicines that can correct the genetic messages that help cancer cells grow out of control.
Investigating whether diet or lifestyle changes could help children cope with bone marrow transplants better.
Understanding how the MYCN protein changes the amounts of other proteins in the cell by changing the way DNA is processed and translated.
Investigating whether giving a medicine before doxorubicin cancer treatment could prevent heart damage.
Looking at how nanoparticles could improve drug delivery and reduce toxicity for young cancer patients.
